|
|
Article: Genentech reapplies for Avastin approval Bay Area biotech firm wants to OK drug for breast cancer treatment
- Article from:
- Oakland Tribune
- Article date:
- August 25, 2007
- Author:
CopyrightCopyright 2007 Oakland Tribune. Provided by ProQuest LLC. (Hide copyright information)
|
Genentech Inc. announced Friday that it has resubmitted an
application seeking approval of its blockbuster cancer drug Avastin
for use with chemotherapy in initial treatment of metastatic breast
cancer.
The South San Francisco-based biotechnology company had hoped to
have the drug already approved for such usage, but last September
the U.S. Food and Drug Administration had questions about the
analysis methods and sought resubmission, said Shiv Kapoor, analyst
with Ferris, Baker Watts in San Francisco.
"I'm hopeful that this data will be approved. And if it does,
it's going to reinvigorate Avastin sales," said Kapoor, who has a
"buy" rating on Genentech.
Avastin has garnered special ...